Table 5.
Item | Treatment group1 | ||
---|---|---|---|
CON-2 | K88 | K88 + APK | |
Duodenum | |||
Villous height, µm | 496 (22)a | 277 (18)b | 416 (30)c |
Crypt depth, µm | 231 (25) | 286 (8) | 293 (26) |
Villous height:crypt depth ratio | 2.31 (0.32)a | 0.97 (0.06)b | 1.44 (0.10)b |
Jejunum | |||
Villous height, µm | 461 (37)a | 289 (12)b | 427 (23)a |
Crypt depth, µm | 204 (15)a | 280 (6)b | 210 (18)a |
Villous height:crypt depth ratio | 2.30 (0.22)a | 1.03 (0.04)b | 2.03 (0.11)a |
Ileum | |||
Villous height, µm | 378 (31)a | 265 (15)b | 353 (30)a |
Crypt depth, µm | 172 (16)a | 269 (9)b | 237 (23)b |
Villous height: crypt depth ratio | 2.30 (0.27)a | 0.99 (0.09)b | 1.56 (0.19)b |
Histologic score | 0.22 (0.32)a | 3.50 (0.65)b | 0.97 (0.21)c |
Diarrhea rate (day 4 to day 6), % | 0 (0)a | 88.9 (17.2)b | 66.6 (29.9)b |
a–cMeans within a row with different superscripts differ (P < 0.05).
1CON-2 = piglets with an oral administration of fresh Luria–Bertani broth (50 mL) followed by an intraperitoneal (i.p.) injection of an equivalent volume of PBS; K88 = piglets orally challenged with 1 × 1010 cfu ETEC K88 on day 1 followed by an i.p. injection of an equivalent volume (1 mL) of PBS; K88 + APK = piglets orally challenged with 1 × 1010 cfu ETEC K88 on day 1 followed by an i.p. injection of 0.6 mg/kg KR-32. n = 6 for the CON-2 group, n = 5 for the K88 group, and n = 5 for the K88 + APK group.